PODD Insulet Corporation

$332.70

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.

Website: https://www.insulet.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1145197
Address
9 OAK PARK DRIVE, BEDFORD, MA, US
Valuation
Market Cap
$17.33B
P/E Ratio
42.70
PEG Ratio
6.26
Price to Book
14.30
Performance
EPS
$5.78
Dividend Yield
—
Profit Margin
20.20%
ROE
43.00%
Technicals
50D MA
$265.32
200D MA
$243.10
52W High
$289.46
52W Low
$160.19
Fundamentals
Shares Outstanding
70M
Target Price
$312.27
Beta
1.30

PODD EPS Estimates vs Actual

● Estimated
● Actual

PODD News & Sentiment

Nov 17, 2025 • Zacks Commentary NEUTRAL
Do Options Traders Know Something About Insulet Stock We Don't?
Investors need to pay close attention to PODD stock based on the movements in the options market lately.
Nov 17, 2025 • Zacks Commentary BULLISH
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
Nov 13, 2025 • Zacks Commentary BULLISH
Why Insulet ( PODD ) Might be Well Poised for a Surge
Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Nov 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Best Momentum Stocks to Buy for Nov. 13
FLEX, PODD and PRAA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Nov. 13, 2025.
Nov 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.
Nov 13, 2025 • Zacks Commentary NEUTRAL
New Strong Buy Stocks for Nov. 13: PODD, PRAA, and More
PFBC, WFRD, PODD, PRAA and ALX have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 13, 2025.
Sentiment Snapshot

Average Sentiment Score:

0.274
50 articles with scored sentiment

Overall Sentiment:

Bullish

PODD Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
0.25 Surprise
  • Reported EPS: $1.17
  • Estimate: $0.92
  • Whisper: —
  • Surprise %: 27.2%
May 08, 2025
Mar 31, 2025 (Post market)
0.23 Surprise
  • Reported EPS: $1.02
  • Estimate: $0.79
  • Whisper: —
  • Surprise %: 29.1%
Feb 20, 2025
Dec 31, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $1.15
  • Estimate: $1.02
  • Whisper: —
  • Surprise %: 12.6%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.14 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.76
  • Whisper: —
  • Surprise %: 18.4%
Aug 08, 2024
Jun 30, 2024 (Post market)
-0.01 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.56
  • Whisper: —
  • Surprise %: -1.8%
May 09, 2024
Mar 31, 2024 (Post market)
0.34 Surprise
  • Reported EPS: $0.73
  • Estimate: $0.39
  • Whisper: —
  • Surprise %: 87.2%
Feb 22, 2024
Dec 31, 2023 (Post market)
0.74 Surprise
  • Reported EPS: $1.40
  • Estimate: $0.66
  • Whisper: —
  • Surprise %: 112.1%
Nov 02, 2023
Sep 30, 2023 (Post market)
0.31 Surprise
  • Reported EPS: $0.71
  • Estimate: $0.40
  • Whisper: —
  • Surprise %: 77.5%
Aug 08, 2023
Jun 30, 2023 (Post market)
0.12 Surprise
  • Reported EPS: $0.38
  • Estimate: $0.26
  • Whisper: —
  • Surprise %: 46.1%

Financials